Suppr超能文献

通过网络药理学和体外实验相结合的方法探索蜜炙甘草(Glycyrrhiza uralensis Fisch.)减轻阿霉素诱导的心肌细胞毒性的有效成分。

Exploring the effective components of honey-processed licorice (Glycyrrhiza uralensis Fisch.) in attenuating Doxorubicin-induced myocardial cytotoxicity by combining network pharmacology and in vitro experiments.

作者信息

Sun Peijun, Chen Huixian, Fan Xiaoyu, Wang Jiayi, Lu Lujie, Yang Guangchao, Liu Jining, Yao Weifeng, Ding Feng, Ding Jie, Liu Jianmei, Lu Tulin, Chen Lihong

机构信息

School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

Advanced Institute of Natural Sciences, Beijing Normal University, Zhuhai, 519087, China.

出版信息

J Ethnopharmacol. 2024 Jul 15;329:118178. doi: 10.1016/j.jep.2024.118178. Epub 2024 Apr 9.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Licorice is widely used clinically as one of the most famous traditional Chinese herbs. Its herb roasted with honey is called honey-processed licorice (HPL). Modern studies have shown that HPL has a stronger cardioprotective ability compared to raw licorice (RL), however the material basis and mechanism of action of the potential cardioprotection have not been fully elucidated.

AIM OF THE STUDY

To screen and validate the material basis of cardioprotection exerted by HPL and to preliminarily predict the potential mechanism of action.

MATERIALS AND METHODS

UPLC-QTOF-MS/MS was used to analyze HPL samples with different processing levels, and differential compounds were screened out through principal component analysis. Network pharmacology and molecular docking were applied to explore the association between differential compounds and doxorubicin cardiomyopathy and their mechanisms of action were predicted. An in vitro model was established to verify the cardioprotective effects of differential compounds.

RESULTS

Six differential compounds were screened as key components of HPL for potential cardioprotection. Based on network pharmacology, 113 potential important targets for the treatment of Dox-induced cardiotoxicity were screened. KEGG enrichment analysis predicted that the PI3K-Akt pathway was closely related to the mechanism of action of active ingredients. Molecular docking results showed that the six differential compounds all had good binding activity with Nrf2 protein. In addition, in vitro experiments had shown that five of the active ingredients (liquiritin, isoliquiritin, liquiritigenin, isoliquiritigenin, and licochalcone A) can significantly increase Dox-induced H9c2 cell viability, SOD activity, and mitochondrial membrane potential, significantly reduces MDA levels and inhibits ROS generation.

CONCLUSION

Liquiritin, isoliquiritin, liquiritigenin, isoliquiritigenin and licochalcone A are key components of HPL with potential cardioprotective capabilities. Five active ingredients can alleviate Dox-induced cardiotoxicity by inhibiting oxidative stress and mitochondrial damage.

摘要

民族药理学相关性

甘草作为最著名的传统中药之一,在临床上被广泛应用。其蜜炙后的药材称为蜜炙甘草(HPL)。现代研究表明,与生甘草(RL)相比,HPL具有更强的心脏保护能力,然而潜在心脏保护作用的物质基础和作用机制尚未完全阐明。

研究目的

筛选并验证HPL发挥心脏保护作用的物质基础,并初步预测其潜在作用机制。

材料与方法

采用超高效液相色谱-四极杆飞行时间串联质谱(UPLC-QTOF-MS/MS)分析不同炮制程度的HPL样品,通过主成分分析筛选差异化合物。应用网络药理学和分子对接技术探讨差异化合物与阿霉素心肌病之间的关联,并预测其作用机制。建立体外模型验证差异化合物的心脏保护作用。

结果

筛选出6种差异化合物作为HPL潜在心脏保护的关键成分。基于网络药理学,筛选出113个治疗阿霉素诱导的心脏毒性的潜在重要靶点。KEGG富集分析预测PI3K-Akt通路与活性成分的作用机制密切相关。分子对接结果表明,6种差异化合物均与Nrf2蛋白具有良好的结合活性。此外,体外实验表明,5种活性成分(甘草苷﹑异甘草苷﹑甘草素﹑异甘草素和甘草查尔酮A)可显著提高阿霉素诱导的H9c2细胞活力、超氧化物歧化酶(SOD)活性和线粒体膜电位,显著降低丙二醛(MDA)水平并抑制活性氧(ROS)生成。

结论

甘草苷﹑异甘草苷﹑甘草素﹑异甘草素和甘草查尔酮A是HPL具有潜在心脏保护能力的关键成分。5种活性成分可通过抑制氧化应激和线粒体损伤减轻阿霉素诱导的心毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验